Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Erica Finolezzi
Prospective Phase II Single-Center Study of the Safety of a Single Very High Dose of Liposomal Amphotericin B for Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Invasive Candida Infections in Patients With Haematological Malignancies and Hematopoietic Stem Cell Transplant Recipients: Current Epidemiology and Therapeutic Options.
Mediterranean Journal of Hematology and Infectious Diseases
Infectious Diseases
Hematology
Related publications
A Phase II Study of Bortezomib in Combination With Pegylated Liposomal Doxorubicin for Acute Myeloid Leukemia
American Journal of Hematology
Hematology
Efficacy and Safety of Enoxaparin for Prophylaxis of Postoperative Venous Thromboembolism After Esophagectomy: A Single-Center Prospective Randomized Controlled Phase II Study
Anticancer Research
Medicine
Cancer Research
Oncology
Improving Outcomes for Patients With Acute Myeloid Leukemia in First Relapse: A Single Center Experience
American Journal of Hematology
Hematology
Spontaneous Remission of Acute Myeloid Leukemia – A Single Center Case Reports
Klinicka Onkologie
Oncology
Evaluation of Renal Toxicity and Antifungal Activity of Free and Liposomal Amphotericin B Following a Single Intravenous Dose to Diabetic Rats With Systemic Candidiasis.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
A Phase I Study of Selinexor in Combination With High-Dose Cytarabine and Mitoxantrone for Remission Induction in Patients With Acute Myeloid Leukemia
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
A Phase II Study of AZD2171 (Cediranib) in the Treatment of Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Patients With Acute Myeloid Leukemia andRASMutations Benefit Most From Postremission High-Dose Cytarabine: A Cancer and Leukemia Group B Study
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology